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Effects of Different Treatments and Doses of Meloxicam After İnsemination 
Pregnancy Rate at Dairy Heifers 
 
SUMMARY 
 
In this study, it was aimed to eliminating of negative effect following suppressing 
PGF2α and long-term inhibition of COX-2 enzymes by using of half dosage -non-steroidal 
anti-inflammatory drug meloxicam at 15 – 17th day of the cycle. 
A total of 75 Holstein heifers aged between 15-16 months were used in the study. 
Natural PGF2α were injected to the heifers for oestrus synchronising. After injections, the 
heifers showed clinical eostrus behavious were inseminated artificially. Animals were 
grouped as in 3 equal groups. The groups were meloxicam with single dossage (n=25), with 
two dossages (n=25) and control group (n=25), respectively. In the first study group, animals 
were received as single meloxicam injection 0.25 mg/kg at 15th day post insemination. In 
second group, they were received meloxicam injections 0,125 mg/kg at 15th and 16th days 
post insemination subcutaneously.  
During pregnancy diagnosis examinations between 35 and 45 days after inseminations, 
pregnancies were recorded in 15 heifers in first study group, 16 heifers in second study group 
and 15 heifers in control group. Pregnancy rates in study groups were determined as 60%, 
64% and 60%, respectively. No significant differences in pregnancy rate of groups were 
determined (p > 0.05). The mean blood P4 concentrations at 10th day were 3.32 ± 1.47 ng/ml, 
3,20 ± 1,20 ng/ml and 3,53 ± 2,15 ng/ml in the animals of single dose-meloxicam, two dose-
meloxicam and control groups, respectively. There was no statistical differences in the mean 
blood P4 concentrations at 10th day among the groups (p > 0.05). The mean blood serum P4 
concentrations at 15th day were detected as 3.22 ± 1.40 ng/ml, 3.17 ± 1.71 ng/ml and 3.41 ± 
2.09 ng/ml in the study groups, respectively and there was no statistical differences in the 
mean blood P4 concentrations (p > 0,05). At day of 20th, P4 concentrations of animals in each 
group were 2.80 ± 0.90 ng/ml, 3.10 ± 2.02 ng/ml and 3.41 ± 1.56 ng/ml and there was no 
statistical difference between mean P4 values of each group, however P4 concentrations in 
control group animals were higher than both meloxicam groups. 
As a result, it was determined that both meloxicam applications on day 15 has no 
positive effects on pregnancy rates, and also possible non-significantly decreasing effects on 
the progesterone levels. 
 
